Effects of Tisseel fibrin glue on the central nervous system of nonhuman primates

Ear, Nose and Throat Journal

Volumn 83, Issue 4, 2004, Pages 246-256

  Kassam, Amin ^a,b   Nemoto, Edwin ^a   Balzer, Jeffrey ^a   Rao, Gutti ^a   Welch, William C ^a   Kuwabara, Hiroto ^a   Boada, Fernando ^a   Horowitz, Michael ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE; GLUCOSE; INTERLEUKIN 6; NEURON SPECIFIC ENOLASE; PROTEIN;

ADHESION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CERVICAL SPINAL CORD; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVOKED SOMATOSENSORY RESPONSE; HISTOPATHOLOGY; INFLAMMATION; LIQUORRHEA; MACACA; MEDIAN NERVE; MONKEY; NEUROSURGERY; NEUROTOXICITY; NONHUMAN; PRIMATE; SAFETY; SKULL SURGERY; STATISTICAL SIGNIFICANCE;

EID: 2042497977     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130408300413     Document Type: Article

References (41)

1. Cain JE, Jr., Dryer RF, Barton BR. Evaluation of dural closure techniques. Suture methods, fibrin adhesive sealant, and cyanoacrylate polymer. Spine 1988;13:720-5.
2. Crockard HA. The transoral approach to the base of the brain and the upper cervical cord. Ann R Coll Surg Engl 1985;67:321-5.
3. D'Arrigo C, Landolt AM. Fibrin sealing of mucoperichondrial flaps in endonasal-transsphenoidal pituitary surgery: Technical note. Neurosurgery 1994;35:529-31.
4. de Vries J, Menovsky T, van Gulik S, Wesseling P. Histological effects of fibrin glue on nervous tissue: A safety study in rats. Surg Neurol 2002;57:415-22.
5. Hadley MN, Martin NA, Spetzler RF, et al. Comparative transoral dural closure techniques: A canine model. Neurosurgery 1988; 22:392-7.
6. Jackson MR, Alving BM. Fibrin sealant in preclinical and clinical studies. Curr Opin Hematol 1999;6:415-19.
7. Knoringer P. Use of fibrin glue for sealing and prophylaxis of cranial and spinal CSF fistulae: Indications, technique and results. In: Schlag G, Redl H, eds. Fibrin Sealant in Operative Medicine. Ophthalmology-Neurosurgery. Vol. 2. Berlin; Heidelberg: Springer-Verlag, 1986:148-56.
8. Lenzi B, Cantini R, Parenti G. Importance of the use of Tissucol (Tisseel) in the reparation of the dura. In: Schlag G, Redl H, eds. Fibrin Sealant in Operative Medicine. Ophthalmology-Neurosurgery. Vol. 2. Berlin; Heidelberg: Springer-Verlag, 1986:145-7.
9. Pomeranz S, Constantini S, Umansky F. The use of fibrin sealant in cerebrospinal fluid leakage. Neurochirurgia (Stuttg) 1991;34: 166-9.
10. Van Velthoven V, Clarici G, Auer LM. Fibrin tissue adhesive sealant for the prevention of CSF leakage following transsphenoidal microsurgery. Acta Neurochir (Wien) 1991;109:26-9.
11. Waldbaur H, Fahlbusch R. The use of fibrin sealant in the neurosurgical treatment of lesions of the base of the skull. In: Schlag G, Redl H, eds. Fibrin Sealant in Operative Medicine. Ophthalmology-Neurosurgery. Vol. 2. Berlin; Heidelberg: Springer-Verlag, 1986:176-80.
12. Siedentop KH, Park JJ, Shah AN, et al. Safety and efficacy of currently available fibrin tissue adhesives. Am J Otolaryngol 2001;22:230-5.
13. Lee KR, Betz AL, Keep RF, et al. Intracerebral infusion of thrombin as a cause of brain edema. J Neurosurg 1995;83:1045-50.
14. Lee KR, Colon GP, Betz AL, et al. Edema from intracerebral hemorrhage: The role of thrombin. J Neurosurg 1996;84:91-6.
15. Gong C, Boulis N, Qian J, et al. Intracerebral hemorrhage-induced neuronal death. Neurosurgery 2001;48:875-82.
16. Lee KR, Drury I, Vitarbo E, Hoff JT. Seizures induced by intracerebral injection of thrombin: A model of intracerebral hemorrhage. J Neurosurg 1997;87:73-8.
17. Banninger H, Hardegger T, Tobler A, et al. Fibrin glue in surgery: Frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 1993:85:528-32.
18. Chouhan VD, De La Cadena RA, Nagaswami C, et al. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: Effects on blood coagulation, protein C activation, and platelet function. Thromb Haemost 1997;77:343-9.
19. Patterson C, Stouffer GA, Madamanchi N, Runge MS. New tricks for old dogs: Nonthrombotic effects of thrombin in vessel wall biology. Circ Res 2001;88:987-97.
20. Rapaport SI, Zivelin A, Minow RA, et al. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. Am J Clin Pathol 1992;97:84-91.
21. Spero JA. Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients. Report of three cases. J Neurosurg 1993;78:817-20.
22. Shekarriz B, Stoller ML. The use of fibrin sealant in urology. J Urol 2002;167:1219-25.
23. Moor-Jankowski J, Socha WW. Blood groups of macaques: A comparative study. J Med Primatol 1978;7:136-45.
24. Socha WW, Moor-Jankowski J, Ruffie J. Blood groups of primates: Present status, theoretical implications and practical implications: A review. J Med Primatol 1984;13:11-40.
25. Hawkey C. Coagulation, fibrinolysis and platelet function. In: Fiennes RN, ed. Pathology of Simian Primates. Part I. Basel; New York: Karger, 1972:318-30.
26. Stolte LA. Pregnancy in the rhesus monkey. In: Bourne GH, ed. The Rhesus Monkey. Vol II. New York: Academic Press, 1975: 171-230.
27. Ghulam Muhammad AK, Yoshimine T, Maruno M, et al. Topical application of fibrin adhesive in the rat brain: Effects on different cellular elements of the wound. Neurol Res 1997;19:84-8.
28. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258-64.
29. Sellman M, Ivert T, Ronquist G, et al. Central nervous system damage during cardiac surgery assessed by 3 different biochemical markers in cerebrospinal fluid. Scand J Thorac Cardiovasc Surg 1992;26:39-45.
30. Jaquiss RD, Ghanayem NS, Zacharisen MC, et al. Safety of aprotinin use and re-use in pediatric cardiothoracic surgery. Circulation 2002;106(suppl 1):I90-4.
31. Cervantes M, Antonio-Ocampo A, Ruelas R, et al. Effects of diazepam on fentanyl-induced epileptoid EEG activity and increase of multineuronal firing in limbic and mesencephalic brain structures. Arch Med Res 1996;27:495-502.
32. Kofke WA, Garman RH, Stiller RL, et al. Opioid neurotoxicity: Fentanyl dose-response effects in rats. Anesth Analg 1996;83: 1298-1306.
33. Sinz EH, Kofke WA, Garman RH. Phenytoin, midazolam, and naloxone protect against fentanyl-induced brain damage in rats. Anesth Analg 2000;91:1443-9.
34. Becker KJ. Targeting the central nervous system inflammatory response in ischemic stroke. Curr Opin Neurol 2001;14:349-53.
35. Block F, Peters M, Nolden-Koch M. Expression of IL-6 in the ischemic penumbra. Neuroreport 2000;11:963-7.
36. Hill JK, Gunion-Rinker L, Kulhanek D, et al. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res 1999;820:45-54.
37. Qureshi AI, Suri MF, Ling GS, et al. Absence of early proinflammatory cytokine expression in experimental intracerebral hemorrhage. Neurosurgery 2001;49:416-20.
38. Stelmasiak Z, Koziol-Montewka M, Dobosz B, Rejdak K. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients. Med Sci Monit 2001;7:914-18.
39. Aksamit AJ, Jr., Preissner CM, Homburger HA. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease. Neurology 2001;57:728-30.
40. Herrmann M, Curio N, Jost S, et al. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry 2001;70: 95-100.
41. Woertgen C, Rothoerl RD, Brawanski A. Time profile of neuron specific enolase serum levels after experimental brain injury in rat. Acta Neurochir suppl 2000;76:371-3.